SkinHealth Systems annual free cash flow
2019
2020
2021
2022
2023
2024
2025
SkinHealth Systems Free Cash Flow (FCF) History (SKIN)
SkinHealth Systems reported $37.2M in free cash flow for fiscal 2025, an increase of 141.79% from the previous fiscal year, with a free cash flow margin of 12.36%.
View full SkinHealth Systems company overviewSkinHealth Systems free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | $37.2M | $21.8M | +141.79% | +12.36% |
| 2024 | 2024-12-31 | $15.4M | −$2.5M | −14.21% | +4.60% |
| 2023 | 2023-12-31 | $17.9M | $135.4M | — | +4.50% |
| 2022 | 2022-12-31 | −$117.4M | −$77.9M | — | −32.10% |
| 2021 | 2021-12-31 | −$39.6M | −$23.6M | — | −15.21% |
| 2020 | 2020-12-31 | −$15.9M | −$8.9M | — | −13.38% |
| 2019 | 2019-12-31 | −$7.0M | — | — | −4.23% |
SkinHealth Systems quarterly free cash flow
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $2.2M | −$7.3M | −76.51% | +3.11% |
| Q1 2026 | 2026-03-31 | −$5.8M | −$8.7M | — | −8.90% |
| Q4 2025 | 2025-12-31 | $15.1M | −$1.3M | −8.18% | +18.28% |
| Q3 2025 | 2025-09-30 | $9.6M | −$691,000 | −6.70% | +13.62% |
| Q2 2025 | 2025-06-30 | $9.6M | $3.7M | +62.84% | +12.22% |
| Q1 2025 | 2025-03-31 | $3.0M | $20.1M | — | +4.24% |
| Q4 2024 | 2024-12-31 | $16.4M | $21.6M | — | +19.64% |
| Q3 2024 | 2024-09-30 | $10.3M | −$7.5M | −42.04% | +13.08% |
| Q2 2024 | 2024-06-30 | $5.9M | −$14.8M | −71.60% | +6.48% |
| Q1 2024 | 2024-03-31 | −$17.2M | −$1.9M | — | −21.13% |
| Q4 2023 | 2023-12-31 | −$5.2M | $1.2M | — | −5.37% |
| Q3 2023 | 2023-09-30 | $17.8M | $53.5M | — | +18.26% |
| Q2 2023 | 2023-06-30 | $20.7M | $54.4M | — | +17.59% |
| Q1 2023 | 2023-03-31 | −$15.3M | $26.3M | — | −17.77% |
| Q4 2022 | 2022-12-31 | −$6.4M | −$3.3M | — | −6.48% |
| Q3 2022 | 2022-09-30 | −$35.7M | −$35.9M | — | −40.21% |
| Q2 2022 | 2022-06-30 | −$33.8M | $3.3M | — | −32.61% |
| Q1 2022 | 2022-03-31 | −$41.6M | −$42.1M | — | −55.19% |
| Q4 2021 | 2021-12-31 | −$3.1M | −$1.8M | — | −3.94% |
| Q3 2021 | 2021-09-30 | $148,000 | — | — | +0.22% |
| Q2 2021 | 2021-06-30 | −$37.1M | — | — | −55.76% |
| Q1 2021 | 2021-03-31 | $443,000 | — | — | +0.93% |
| Q3 2020 | 2020-09-30 | −$1.3M | — | — | −3.67% |
SkinHealth Systems free cash flow growth trends
Over the last five reported fiscal years, free cash flow grew from −$15.9M to $37.2M, a net increase of $53.1M. SkinHealth Systems's latest reported quarter, Q2 2026, generated $2.2M in free cash flow, a decrease of 76.51% year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review SkinHealth Systems filings at SEC.gov ↗